Clinical Trial Detail

NCT ID NCT04109456
Title IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors InxMed (Shanghai) Co., Ltd.
Indications

uveal melanoma

melanoma

Therapies

BI 853520 + Cobimetinib

BI 853520

Age Groups: adult senior

Additional content available in CKB BOOST